Genomic features of pneumococcal strains isolated from paediatric patients with invasive disease during pneumococcal conjugate vaccine introduction in Lima, Peru. [PDF]
Gonzales BE +6 more
europepmc +1 more source
Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective. [PDF]
Mendes D +9 more
europepmc +1 more source
Population-based surveillance for pneumonia, sepsis and meningitis in all ages in The Gambia: Implications for pneumococcal vaccine introduction and surveillance in Africa [PDF]
D. Nsekpong +41 more
core +1 more source
Effectiveness of 10-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia and invasive pneumococcal disease among young children in Mozambique. [PDF]
Sigaúque B +14 more
europepmc +1 more source
Evaluation of efficacy and effectiveness across the pneumococcal conjugate vaccine era. [PDF]
LaFon DC.
europepmc +1 more source
Association between introduction of 13-valent pneumococcal conjugate vaccine and burden of hospitalized adult pneumococcal disease in Hong Kong - A retrospective database study. [PDF]
Yu Q +8 more
europepmc +1 more source
Pneumococcal conjugate vaccine and pneumococcal common protein vaccines
Keith P. Klugman +4 more
openaire +1 more source
Cross reactivity within pneumococcal serogroups 6 and 15 following adult vaccination with pneumococcal conjugate vaccine V116. [PDF]
Li J +7 more
europepmc +1 more source
III. Characteristics and Differences in Pneumococcal Vaccines; 2. Pneumococcal Conjugate Vaccine
openaire +3 more sources
Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine Versus a 13-Valent Vaccine in Infants: A Systematic Review and Meta-Analysis. [PDF]
Pacheco-Haro MD +8 more
europepmc +1 more source

